IT201600130012A1 - Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale - Google Patents
Composizione per uso nel trattamento di disturbi dell'apparato uro-genitaleInfo
- Publication number
- IT201600130012A1 IT201600130012A1 IT102016000130012A IT201600130012A IT201600130012A1 IT 201600130012 A1 IT201600130012 A1 IT 201600130012A1 IT 102016000130012 A IT102016000130012 A IT 102016000130012A IT 201600130012 A IT201600130012 A IT 201600130012A IT 201600130012 A1 IT201600130012 A1 IT 201600130012A1
- Authority
- IT
- Italy
- Prior art keywords
- disorders
- treatment
- composition
- urogenital system
- urogenital
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102016000130012A IT201600130012A1 (it) | 2016-12-22 | 2016-12-22 | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale |
EP17832350.7A EP3558459A1 (en) | 2016-12-22 | 2017-12-21 | Composition for use in the treatment of disorders of the urogenital apparatus |
RU2019122801A RU2019122801A (ru) | 2016-12-22 | 2017-12-21 | Композиция для применения при лечении нарушения мочеполовой системы |
PCT/IB2017/058284 WO2018116238A1 (en) | 2016-12-22 | 2017-12-21 | Composition for use in the treatment of disorders of the urogenital apparatus |
CN201780086737.1A CN110300616A (zh) | 2016-12-22 | 2017-12-21 | 用于治疗泌尿生殖器官的病症的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102016000130012A IT201600130012A1 (it) | 2016-12-22 | 2016-12-22 | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201600130012A1 true IT201600130012A1 (it) | 2018-06-22 |
Family
ID=58670171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102016000130012A IT201600130012A1 (it) | 2016-12-22 | 2016-12-22 | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3558459A1 (it) |
CN (1) | CN110300616A (it) |
IT (1) | IT201600130012A1 (it) |
RU (1) | RU2019122801A (it) |
WO (1) | WO2018116238A1 (it) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3097436B1 (fr) * | 2019-06-24 | 2023-10-13 | Oreal | Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose |
IT201900021483A1 (it) * | 2019-11-18 | 2021-05-18 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Composizioni comprendenti xiloglucano e D-mannosio e loro uso per il trattamento di disturbi del tratto genito-urinario |
CA3161779A1 (en) * | 2019-12-19 | 2021-06-24 | An-Katrien VYNCKIER | Compositions and methods for managing infections of a urinary tract |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056380A2 (en) * | 2002-12-23 | 2004-07-08 | Forum Bioscience Holdings Limited | Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
JP2007137797A (ja) * | 2005-11-16 | 2007-06-07 | Ss Pharmaceut Co Ltd | ウワウルシ乾燥エキス含有経口製剤 |
WO2007144778A2 (en) * | 2006-02-22 | 2007-12-21 | Biologic Health Solutions Pty Ltd. | Herbal compositions for the prevention or treatment of a urinary tract infection |
US20090180999A1 (en) * | 2008-01-11 | 2009-07-16 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition |
WO2012123491A1 (en) * | 2011-03-15 | 2012-09-20 | Velleja Research S.R.L. | Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e |
WO2016027226A1 (en) * | 2014-08-19 | 2016-02-25 | Kolinpharma S.P.A. | A composition for the treatment and prevention of urinary tract infections |
-
2016
- 2016-12-22 IT IT102016000130012A patent/IT201600130012A1/it unknown
-
2017
- 2017-12-21 EP EP17832350.7A patent/EP3558459A1/en active Pending
- 2017-12-21 RU RU2019122801A patent/RU2019122801A/ru not_active Application Discontinuation
- 2017-12-21 WO PCT/IB2017/058284 patent/WO2018116238A1/en unknown
- 2017-12-21 CN CN201780086737.1A patent/CN110300616A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056380A2 (en) * | 2002-12-23 | 2004-07-08 | Forum Bioscience Holdings Limited | Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
JP2007137797A (ja) * | 2005-11-16 | 2007-06-07 | Ss Pharmaceut Co Ltd | ウワウルシ乾燥エキス含有経口製剤 |
WO2007144778A2 (en) * | 2006-02-22 | 2007-12-21 | Biologic Health Solutions Pty Ltd. | Herbal compositions for the prevention or treatment of a urinary tract infection |
US20090180999A1 (en) * | 2008-01-11 | 2009-07-16 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition |
WO2012123491A1 (en) * | 2011-03-15 | 2012-09-20 | Velleja Research S.R.L. | Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e |
WO2016027226A1 (en) * | 2014-08-19 | 2016-02-25 | Kolinpharma S.P.A. | A composition for the treatment and prevention of urinary tract infections |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 200739, Derwent World Patents Index; AN 2007-409294, XP002772909 * |
Also Published As
Publication number | Publication date |
---|---|
RU2019122801A3 (it) | 2021-03-26 |
WO2018116238A1 (en) | 2018-06-28 |
RU2019122801A (ru) | 2021-01-22 |
EP3558459A1 (en) | 2019-10-30 |
CN110300616A (zh) | 2019-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2400004I1 (hu) | Diaminopirimidin-P2X3 és P2X2/3 receptor modulátorok felhasználásra köhögés kezelésében | |
DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
IT201600101413A1 (it) | Composizione liquida per uso nel trattamento del reflusso gastroesofageo | |
IL256350A (en) | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
MA42497A (fr) | Procédés et compositions pour la régulation sélective de l'expression protéique | |
ITUA20162575A1 (it) | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa | |
DK3529234T3 (da) | Forbindelser, fremgangsmåde til opnåelse af forbindelserne, farmaceutisk sammensætning, anvendelse af forbindelserne og fremgangsmåde til behandling af psykiatriske lidelser og/eller søvnforstyrrelser | |
IT201600130012A1 (it) | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale | |
DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
IT201700085412A1 (it) | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare | |
MX371343B (es) | Moduladores del receptor x hepatico (lxr). | |
PH12016501658A1 (en) | Sialylated glycoprotein compositions and uses thereof | |
IT201600122310A1 (it) | Composizione per uso nella terapia di alterazioni dell'intestino | |
IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
ITUB20153759A1 (it) | Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo | |
DK3442537T3 (da) | (+)-azasetron til anvendelse i behandlingen af ørelidelser | |
ITUA20163037A1 (it) | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici | |
ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
IT201700035964A1 (it) | “divisorio per boiserie” | |
ITUA20162343A1 (it) | Formulazioni intranasali di bdnf per uso nel trattamento di malattie neurodegenerative |